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Matrix metalloproteinases (MMPs) cooperatively degrade all components of the extracellular matrix (ECM). Remodeling of
ECM during skeletal muscle degeneration and regeneration suggests a tight regulation of matrix-degrading activity during
muscle regeneration. In this study, we investigated the expression of MMP-2 and MMP-9, in normal muscles and their
regulation during regeneration process. We further investigated their secretion by C2C12 myogenic cell line. Two models
of muscle degeneration–regeneration were used: (1) normal muscles in which necrosis was experimentally induced by
cardiotoxin injection; (2) mdx muscles which exhibit recurrent signs of focal myofiber necrosis followed by successful
regeneration. MMPs were studied by zymography; their free activity was quantified using 3H-labeled gelatin substrate and
RNA expression was followed by Northern hybridization. Muscle degeneration–regeneration was analyzed by conven-
ional morphological methods and in situ hybridization was performed on muscle sections to identify the cells expressing
hese MMPs. Results show that MMP-2, but not MMP-9 expression, is constitutive in normal muscles. Upon injury, the
ctive form of MMP-2 is transiently increased, whereas MMP-9 is induced within 24 h and remains present for several days.
uantitative assays of free gelatinolytic activity show a progressive and steady increase that culminates at 7 days postinjury
nd slowly returns to normal levels. In adult mdx mice, both pro and active forms of MMP-2 and MMP-9 are expressed.
orthern blot results support these findings. Zymography of C2C12-conditioned medium shows that myogenic cells
roduce MMP-2. By in situ hybridization we localized MMP-9 mRNA in inflammatory cells and putative activated satellite
ells in injured muscles. Our data allow the correlation of the differential expression of pro and/or active forms of MMP-2
nd MMP-9 with different stages of the degeneration–regeneration process: MMP-9 expression is related to the inflamma-
ory response and probably to the activation of satellite cells, whereas MMP-2 activation is concomitant with the
egeneration of new myofibers. © 1999 Academic Press
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The extracellular matrix (ECM) plays a central role in
maintaining the structural integrity of primitive multicel-
lular organisms as well as that of highly complex mammals.
Degradation and synthesis of several macromolecular com-
ponents of ECM have been demonstrated after injury to
adult myofibers (Gulati et al., 1983). These multinucleateda
F
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158yncitia arise from the fusion of mononucleated precursors,
he myoblasts, which continue to fuse with adjacent myo-
bers during postnatal growth, and persist in mature
uscle as “satellite cells” (Mauro, 1961) providing a source
f cells for new muscle formation during muscle regenera-
ion. Injury to a muscle induces the necrosis of affected
yofibers and their subsequent regeneration which results
rom the activation, proliferation, and fusion of the myo-
enic mononucleated stem cells into centrally multinucle-
ted myotubes that mature into myofibers (Carlson and
aulkner, 1983; Plaghki, 1985). This degeneration–
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159MMP-2 and MMP-9 in Regenerating Muscleregeneration process occurs in several genetically inherited
myopathies such as Duchenne muscular dystrophy (DMD)
and its murine homologue, mdx mice (Bulfield, 1984),
haracterized by recurrent signs of degeneration–
egeneration, and results from the absence of dystrophin, a
ubsarcolemmal cytoskeletal protein that contributes to
yofiber integrity. It can also be experimentally induced in
ormal muscles by several myotoxic agents (Duchen et al.,
974; Harris, 1975; Plaghki, 1985). Regeneration clearly
equires migration of the myoblasts to the fusion site
Grounds and Davies, 1996; Schultz et al., 1985) and has
een shown to occur in vivo (Hauschka, 1994). On the other
and, there is evidence of extensive remodeling of ECM
olecules during myoblast fusion (Chen, 1977), synapse
limination in neonatal development (Hantaı¨ et al., 1989),
nd muscle degeneration–regeneration under experimental
onditions (Gulati et al., 1982, 1983). Previous work has
emonstrated the ability of myoblasts to secrete ECM-
egrading enzymes (Gue´rin and Holland, 1995; Strittmatter
nd Couch, 1986; Strittmatter et al., 1982), but little is
nown about their ability to participate directly in the
emodeling of the ECM.
Among the enzymes involved in matrix degradation is a
roup of zinc metalloproteinases known as matrix metallo-
roteinases (MMPs). These enzymes share similar charac-
eristics including a common mode of activation, conserved
mino acid sequences in the putative metal binding active
ite region, and inhibition by specific proteinase inhibitors
nown as the tissue inhibitors of metalloproteinases
TIMPs) (Edwards et al., 1996). The final in vivo level of
egradative activity is thought to result from the interac-
ions of many factors controlling expression and activation
f latent enzymes and interaction of active enzymes with
nhibitors as well as their inactivation and degradation.
heir balance determines the extent of matrix degradation.
he majority of MMPs are secreted as latent proenzymes
nd can be activated by several factors as other proteinases
r organomercurials such as amino phenyl mercuric acetate
APMA). This activation is characterized by a loss of mo-
ecular weight of approximately 10 kDa (Birkedal-Hansen,
995; Woessner, 1991).
The aim of our work was to study the expression of
MP-2 (72-kDa type IV collagenase; gelatinase A, EC
.4.24.24) and MMP-9 (92-kDa type IV collagenase; gelati-
ase B, EC 3.4.24.35), in normal skeletal muscles and their
ventual induction and/or activation during the
egeneration–regeneration process. We also investigated
heir secretion by C2C12 myogenic cell line. MMP-2 is
ecreted by a wide range of cell types from connective
issues and tumors and has the ability to degrade many
onnective tissue components including denatured fibrillar
ype I (Aimes and Quigley, 1995), II, and III collagens, native
ype IV and V collagen (Birkedal-Hansen, 1995). Addition-
lly, 72-kDa gelatinase is able to degrade elastin (Okada et
l., 1990) and has low activity toward proteoglycan and
bronectin. MMP-9 degrades the same substrates and is
roduced mainly by inflammatory cells including polymor- (
Copyright © 1999 by Academic Press. All righthonuclear leukocytes, macrophages, eosinophils (Stahle-
ackdahl et al., 1994), and lymphocytes (Montgomery et al.,
993) by various tumor cells such as fibrosarcoma HT1080
r leukemic cell HL-60 (Ries et al., 1994) and by normal
ells such as placental cytotrophoblasts, keratinocytes, os-
eoclasts (Tezuka et al., 1994; Wucherpfenning et al., 1994),
nd amniotic epithelial cells (Lehtovirta and Vartio, 1994).
uman myogenic cells have been shown to produce and
ecrete MMPs (Gue´rin and Holland, 1995) but their expres-
ion in vivo has not been documented. In injured skeletal
uscles, MMPs may act by proteolytically releasing growth
actors from ECM during the regenerative process. These
rowth factors have been shown to stimulate and activate
yogenic cells in vitro (Allen et al., 1995; Bischoff, 1997;
legg et al., 1987) and in vivo (Tatsumi et al., 1998).
The expression and regulation of MMP-2 and MMP-9 in
ormal and remodeling skeletal muscles was carried out
sing two models of degeneration–regeneration: (1) experi-
ental injury induced in normal mice muscles by cardio-
oxin (CTX) injection (Duchen et al., 1974) and (2) sponta-
eous regeneration in mdx mice that share genetic,
iochemical, and histopathological features with DMD
McArdle et al., 1995) and exhibit myofiber necrosis fol-
owed by regeneration.
MATERIALS AND METHODS
Animals
The mice used were 3-month-old C57Bl10/mdx, the murine
model for DMD, and C57Bl10ScSn control strain in which the
mutant mdx originally arose. The latter were used for experimental
induction of muscle injury. Both were maintained as a breeding
colony from stock kindly provided by Dr. T. Partridge (Department
of Histopathology, Charing Cross & Westminster Medical School,
London, UK). The animals were kept at room temperature with a
natural night–day cycle and fed with pellets and water ad libitum.
Experimental Injury of Muscle
Injury of normal muscles was performed by injecting cardiotoxin
(CTX) (Latoxan, France) (0.06 mg/ml) along the longitudinal axis of
he extensor digitorum longus (EDL) and tibialis anterior (TA)
uscles of the C57Bl10 ScSn mice. CTX was released while pulling
ut the needle to deliver myotoxin along the muscle mass. The
xperiments were performed in right hindlimb muscles and con-
ralateral intact muscles were used as controls. Morphological and
iochemical examinations were performed at 1, 3, 7, 10, 14, and 30
ays after injection.
Histological Assessments
At selected times, EDL–TA muscles of the C57Bl10ScSn and
3-month-old mdx mice were removed after cervical dislocation.
They were carefully dissected, mounted with tragacanth gum on a
piece of cork, and frozen in isopentane chilled by liquid nitrogen.
Blocks were stored at 280°C prior to sectioning. Transverse cryo-
stat sections (10 mm thick) were stained with hematoxylin–eosin
H&E).
s of reproduction in any form reserved.
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160 Kherif et al.Tissue Extract Preparation
The mdx and CTX-treated muscles were immediately frozen in
iquid nitrogen (2165°C) and preserved at 280°C. Muscles were
eighed and homogenized (1:10, w/v) in extraction buffer 100 mM
ris–HCl, pH 7.6, 200 mM NaCl, 100 mM CaCl2 and 1% Triton
X-100 at 4°C. After centrifugation (15,000g), the supernatant was
divided into aliquots, and protein concentration was determined
against an albumin standard curve using the Micro BCA kit
(Pierce). Equal amounts of total protein were loaded for zymogra-
phy (60 mg/lane) and Western blotting (100 mg/lane). For the
3H-labeled gelatin assay, three tissue samples per time point were
ooled and the assay was performed in triplicate.
Cell Culture
Frozen C2C12 myogenic cells were thawed and cultured in
DMEM medium (GIBCO) in presence of 20% fetal calf serum
(GIBCO) and 0.5 mg/ml gentamycin (GIBCO). Cells (106) were
plated in 36-mm culture dish and allowed to attach for 16–17 h in
complete medium. They were rinsed in 13 PBS (phosphate-
buffered saline) and fresh DMEM with no serum added. C2C12-
conditioned medium was collected after 48 h of incubation and 20
ml was analyzed by gelatin zymography.
Zymography
Zymography of muscle extracts and conditioned medium of
C2C12 cell line was carried out according to Heussen and Dowdle
[Heussen, 1980]. Zymogram gels consisted of 7.5% polyacrylamide
impregnated with gelatin at 1 mg/ml. After electrophoresis, the
gels were washed twice for 30 min in a 2.5% Triton X-100 solution
at room temperature and incubated for 24 h in a substrate buffer (50
mM Tris–HCl buffer, pH 8.0, 5 mM CaCl2, 0.02% NaN3) at 37°C.
Metalloproteinases are secreted in a latent form and require cleav-
age of a peptide from their NH2 terminus for activation. However,
exposure of proenzymes of the tissue extracts to SDS during gel
separation procedure leads to activation without proteolytic cleav-
age (Talhouk et al., 1991). The gels were then stained in Coomassie
blue R250 for 1 h and destained in water overnight. Gelatin-
degrading enzymes were visualized as clear bands, indicating
proteolysis of the substrate protein.
Gelatinase Assay on Radiolabeled Gelatin
Free gelatinase activity was assayed using radiolabeled gelatin as
substrate. Gelatin (Sigma) was radiolabeled with 3H-labeled acetic
nhydride (Lafuma et al., 1994). Specific activity was 880 kBq/mg.
o measure the free form of gelatinase, aliquots of muscle extracts
ere incubated in the presence of 50 mg of acetylated 3H-labeled
elatin. The proteolytic reaction was allowed to proceed for 48 h at
7°C, pH 7.4, in the presence of toluene to prevent bacterial
ontamination. Gelatin was precipitated at 4°C with a mixture of
richloroacetic and tannic acid to a final concentration of 4 and
.8%, respectively. The reaction media were centrifuged at 6000g
or 10 min at 4°C. Aliquots of the resulting supernatants were
ixed with equal volumes of scintillation liquid (optiphase “Hisafe
”) and counted for radioactivity in a 1209 Rackbeta LKB counter
nstrument. Results are expressed as micrograms of gelatin hydro-
yzed per 48 h per muscle.
b
Copyright © 1999 by Academic Press. All rightCharacterization of Metalloproteinases
To characterize the MMP activity, specific enzyme inhibitors or
APMA (Sigma), a known MMP activator, were added to incubation
media. In one series of experiments, the serine protease inhibitor
AEBSF (Calbiochem) (1 mM), cysteine protease E64 (Calbiochem)
(10 mM), and metalloproteinases inhibitor EDTA (Sigma) (10 mM)
were used for activity assay on 3H-labeled gelatin, whereas EDTA
(20 mM) and PMSF (Sigma) (1 mM) were added to the incubation
buffer after gel electrophoresis. In a second set of experiments,
APMA (1 mM) was mixed with the samples and incubated for 1 h
at room temperature before being analyzed by zymography.
Western Blot Procedures
Tissue extracts were submitted to SDS–PAGE using 7.5% poly-
acrylamide gels (Laemmli, 1970) under nonreducing conditions.
The proteins were transferred onto a nitrocellulose membrane
(Towbin et al., 1979), and stained with ponceau S (Sigma) in 0.1%
acetic acid. The membrane was blocked with 10% nonfat milk
(Gloria, Nestle´) in PBS and incubated overnight at room tempera-
ture with polyclonal rabbit antibodies against human MMP-2 and
MMP-9 (Valbiotech, France), respectively, diluted at 1:500 and
1:1000 in PBS 13% milk. The membrane was then incubated with
horseradish peroxidase-conjugated anti-rabbit antibody (Dako,
Denmark) at 1:2000 for 1 h at room temperature. After a thorough
wash, the membrane was processed with an enhanced chemilumi-
nescence Western blot analysis system (ECL kit, Amersham). The
immunoreaction was visualized by exposure of the membrane to
X-OMAT films (Kodak).
Northern Blot
Total RNA was extracted and purified from freshly isolated
muscle tissue according to the procedure of Chomczynski and
Sacchi (1987). Ten micrograms of total RNA was resolved in 1.1%
agarose–formaldehyde gels under denaturing conditions and trans-
ferred onto a nylon membrane Hybond N1 (Amersham) by a 24-h
apillary transfer in 203 SSC. The gels were photographed on a UV
ransilluminator to record RNA integrity. RNA was cross-linked to
he membrane by use of the Stratalinker-2400 (Stratagene, La Jolla,
A). Filters were prehybridized at 45°C for 3 h in 50% formamide
Fluka), 203 SSC, 503 Denhardt’s, 10% SDS, 0.5 M Pipes (Sigma),
H 6.4, 0.5 M EDTA (Promega), and 5 mg/ml denatured salmon
perm DNA (GENBLOC). Hybridizations were carried out under
igh stringency conditions in the same solution at 45°C overnight.
lots were then washed at medium stringency in 13 SSC, 1% SDS
3 times, 15 min) at 55°C and then at 60°C (1 time, 15 min) before
xposure to autoradiography on Kodak X-OMAT films. Blots were
equentially hybridized with a 2.8-kb EcoRI insert in pBR322
lasmid of mouse 72-kDa gelatinase (MMP-2) and a 1.8-kb EcoRI–
indIII insert in pBlueScript II plasmid of mouse 92-kDa gelatinase
MMP-9). The recombinant plasmids were kindly provided by Dr.
. Tryggvason (Department of Medical Biochemistry and Biophys-
cs, Karolinska Institute, Sweden) (Reponen et al., 1992, 1994). To
ormalize signal intensity, blots were later stripped and rehybrid-
zed with an 18S oligoprobe 32P-radiolabeled by nick translation.
The cDNA probes were labeled with [32P]dCTP by random priming
sing the Klenow enzyme (Megaprime DNA labeling system kit,
mersham). Unincorporated radioactivity was removed using
ick Spin columns (Pharmacia). Quantification of the labeledands was performed with a b-imager (Biospace Mesure, France)
using the Biovision computer program.
s of reproduction in any form reserved.
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161MMP-2 and MMP-9 in Regenerating MuscleRadioactive in Situ Hybridization
In situ hybridization was performed to detect the cellular source
of MMP-2 and MMP-9 expression. [35S]UTP-labeled RNA probes
were synthesized using Ampliscribe Sp6 and T7 high yield tran-
scription kit (TEBU). For MMP-9 probe preparation, pSP65 and
pSp64 plasmid containing the M-92 KD-2 clone were respectively
linearized with BamHI (antisense) and EcoRI (sense) and then
transcribed in vitro with Sp6 polymerase to obtain a 323-pb RNA
(Reponen et al., 1994). [35S]UTP-labeled pGEM single-stranded
NA and sense MMP-9 probes were used as negative controls. For
MP-2 probe preparation, pGEM-3Z plasmid containing a mouse
2-kDa type IV collagenase cDNA clone was linearized with EcoRI
antisense) or BamHI (sense) and transcribed in vitro using Sp6 or
T7 polymerase, respectively; this resulted in a 331-pb RNA (Repo-
nen et al., 1992). MMP-2 and MMP-9 cDNA clones were kindly
provided by Dr. K. Tryggvason (Department of Medical Biochem-
istry and Biophysics, Karolinska Institute, Sweden).
At selected times, normal and injured EDL–TA skeletal muscles
were removed under RNase-free conditions, mounted with traga-
canth gum, and immediately frozen in liquid nitrogen; and they
were stored at 280°C until use. Transverse cryostat sections (7 mm)
ere performed, placed on silanized slides, and postfixed in a
reshly prepared solution of formaldehyde 4% in 13 PBS buffer for
5 min. Slides carrying sections were then rinsed in PBS for 15 min
nd quickly dehydrated through a series of ethanols (60, 70, 95, and
00%). Slides were then treated with a fresh solution of 7 mg/ml
proteinase K (Sigma) for 15 min at 37°C in 20 mM Tris–HCl and 2
mM CaCl2, pH 7.4. Slides were then rinsed in sterile distilled water
nd acetylated in a 0.1 M solution of triethanolamine (Fluka) with
cetic anhydride, 0.25% (Fluka) for 10 min. Slides were rinsed with
3 SSC for 5 min (13 SSC 5 0.15 M NaCl, 0.015 M sodium citrate)
and allowed to dry at least 1 h prior to hybridization. Probe was
applied directly to tissue sections at a final adjusted concentration
of 2 3 106 cpm/section in hybridization buffer containing: 50%
deionized formamide (Sigma), Tris–EDTA, NaCl, 13 Denhardt’s,
10% Dextran sulfate (Pharmacia), 1 mg/ml total yeast RNA
(Sigma), 0.5 mg/ml salmon sperm DNA (GENBLOC), and sections
were covered with a siliconized coverslip (14 mm, diameter).
Hybridization was carried out at 50°C for approximately 16 h in a
humidified chamber. Coverslips were gently floated off in 50%
formamide, 43 SSC at room temperature and the tissue was then
subjected to two 15-min washes at 55°C in 50% formamide, 23
SSC, 20 mM b-mercaptoethanol. Slides were then rinsed in 23 SSC
or 10 min at room temperature and treated with RNase A (Sigma)
100 mg/ml, 15 min at 37°C) in washing buffer. Following one wash
n 23 SSC for 30 min at 37°C and two 5-min washes at 20°C, slides
ere rapidly dehydrated in a series of 70, 90, and 100% ethanols.
lides were processed for standard autoradiography using LM-1
odak emulsion and exposed for 2 months in light-tight boxes with
essicant at 4°C. Photographic development was carried out in
ull-strength Kodak D-19. Slides were fixed (Ilford) and lightly
tained with H&E. Analysis was carried out using light-field optics
n a Leica microscope.
RESULTS
Histological Analysis of the Necrotic–Regeneration
ProcessIn contrast to the normal control (Fig. 1a), cross sections
of 3-month-old mdx muscles exhibited the typical appear-
h
c
Copyright © 1999 by Academic Press. All rightance of regenerated muscles with centrally nucleated
muscle fibers of variable size (Fig. 1b). They presented little
if any necrosis and infiltration by invasive cells. CTX-
injured muscles appeared edematous within the first 3 days
by gross morphological observations. At day 1, muscles
were already infiltrated by polymorphonuclear leukocytes
(PMN), predominant within the enlarged intercellular space
separating the pale necrotic myofibers (Fig. 1c). By day 3,
the necrotic fibers were largely invaded by PMN and
macrophages and spindle-shaped mononucleated cells be-
gan to appear (Fig. 1d). At day 7 after injury, the majority of
injured fibers regenerated into groups of centrally nucleated
myotubes (Fig. 1e), whereas a few necrotic fibers infiltrated
by macrophages could occasionally still be observed. At
later stages (Figs. 1f–1h, days 10, 14, and 30), regenerated
myofibers exhibited increase of their cross-sectional area
and further matured into myofibers with central nuclei.
Zymography
Muscle extracts from the different experimental groups
exhibited different zymographic profiles under nonreducing
conditions (Fig. 2). In normal muscles, a major 60-kDa
gelatinase activity was detected in addition to two barely
detectable bands at 66 and 55 kDa. By contrast, in muscle
extracts of mdx mice, two zones of lysis bands one at 100
kDa and the other at 66, 60, and 55 kDa were detected (Fig.
2, mdx). These bands suggested the presence of latent
and/or active forms of MMP-9 (100 kDa) and MMP-2 (66,
60, and 55 kDa). In normal muscles injured by CTX, MMP-9
expression was induced within 24 h after injury and repre-
sented the major gelatinase identified. At more advanced
stages (days 3 and 7) this activity progressively decreased
until it completely disappeared by the beginning of the
second week. At the same time, the active form of MMP-2,
present at low levels in the normal muscle, gradually
increased reaching a maximum 7 days after injury and
concomitant overexpression of 66- and 60-kDa species was
observed. Between days 14 and 30, the pattern and level of
gelatinolytic activity returned to normal. In C2C12-
conditioned medium, a major 60-kDa gelatinase activity
was detected in addition to two bands at 66 and 55 kDa (Fig.
2, CM).
To determine the exact nature of these gelatin-degrading
proteases, we examined the effect of APMA, a known
activator of metalloproteinases, and two protease inhibitors
by zymography. Treatment of extracts from normal
muscles in the presence of 1 mM APMA at 37°C for 1 or 3 h
resulted in an increase of the 55-kDa species (Fig. 3A) which
we interpreted as a conversion of a latent to an active form.
Additionally, the gelatinolytic proteases from mdx muscle
xtracts were completely inhibited in presence of EDTA (20
M), whereas PMSF (1 mM), a serine protease inhibitor,ad no effect on their ability to degrade gelatin (Fig. 3B),
onfirming that they belong to the MMP family.
s of reproduction in any form reserved.
162 Kherif et al.FIG. 1. Pattern of necrosis-regeneration of 3-month-old CTX-injured and mdx TA muscles. (a) Normal, (b) mdx, (c–h) CTX-injured
muscles. Inflammatory cells have invaded the enlarged extracellular space of the edematous muscle at 1 day postinjury (c) and have
completely infiltrated the necrotic myofibers by day 3 (d). Numerous young myotubes have regenerated at day 7 and inflammation has
decreased (e). Maturation of myotubes into multinucleated myofibers progressively occurred (f, 10 days; g, 14 days; and h, 30 days). Cross
sections stained with H&E. Magnification, 3100.
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163MMP-2 and MMP-9 in Regenerating MuscleGelatinase Assays on Radiolabeled Gelatin
To investigate the modulation of free gelatinolytic activ-
ity during the time course of necrosis–regeneration and
determine the precise contribution of gelatinases to the
total degradative activity in CTX-treated muscles, we per-
formed a quantitative gelatinase assay using 3H-labeled
elatin as a substrate in the presence of specific protease
nhibitors. This assay allowed the detection of only free
elatinolytic activity not inhibited by TIMPs of both
MP-2 and MMP-9 since gelatin is a common substrate for
oth enzymes. In tissue extracts from normal muscles, free
elatinolytic activity was very low and could be attributed
o serine proteases on the basis of inhibition profiles. In
TX injured muscles, free gelatinolytic activity was pro-
ressively increased from day 1 postinjury until day 7, when
t reached its maximum, before returning to the normal
evel. The increase measured between days 1 and 10 postin-
ury was mainly due to metalloproteinases (60–90%) with
ome serine and cysteine proteinase activities. At days 14
nd 30, the level of free gelatinolytic activity returned to
he normal values and was associated with serine protease
ctivity (Fig. 4).
Western Blot Analysis
Western blot analysis under nonreducing conditions of CTX
FIG. 2. Zymographic analysis of normal, CTX-injured, and mdx
EDL–TA muscles and conditioned medium of C2C12 myogenic
cell line. Gelatin at 1 mg/ml was copolymerized in 7.5% SDS–
PAGE and equal amounts of protein (60 mg/lane) were loaded. After
lectrophoresis of muscle extracts, the gelatin substrate gels were
ashed twice with Triton X-100 to remove SDS and incubated
vernight in a 100 mM Tris–HCl incubation buffer with CaCl2 at
7°C. Gels were then stained with Coomassie blue and the lysis
reas appear as clear bands. C, 3-month-old normal muscle. 1, 3, 7,
0, 14, and 30 correspond to CTX-injured muscles at 1, 3, 7, 10, 14,
nd 30 days after injury. mdx, 3-month-old mdx muscle; C2C12,
onditioned medium of C2C12 cell line. Molecular weights are on
he left.and mdx muscle extracts with polyclonal antibody against
human MMP-9 revealed the absence of band in normal
Copyright © 1999 by Academic Press. All rightuscles and the presence of one band at 100 kDa in CTX-
reated muscles during the first week after injury and in all
xamined mdx muscles (Fig. 5). This band corresponds to
ouse MMP-9 known to migrate slightly higher than the
uman protein (Unemori et al., 1991). Western blots of
uscle extracts using polyclonal antibodies against human
MP-2 did not allow the detection of mouse MMP-2.
Northern Blot Analysis
Northern blot analysis using cDNA probes for mouse
MMP-9 and MMP-2 was performed on 10 mg of total cytoplas-
ic RNA extracted from normal, CTX-treated, and mdx
uscles to determine whether enzyme expression of these
wo MMPs was controlled at the transcriptional level (Fig.
A). The Northern blot of normal muscles showed the ab-
ence of MMP-9 transcript(s) which is in accordance with the
bsence of MMP-9 protein and its corresponding activity. In
TX-injured muscles, MMP-9 transcripts were induced as
arly as the first day after injury and two transcripts of 3 and
.8 kb were detected. The relative amount of MMP-9 tran-
cripts was maximal at day 1 and progressively decreased
efore disappearing completely at the beginning of the second
eek (Fig. 6B). In mdx muscles, we could not detect MMP-9
ranscripts in 3-month-old mice. MMP-9 transcripts were also
ndetectable in younger mice (1 month old) undergoing active
ecrosis and regeneration even when higher amounts (30 mg)
f total RNA were loaded. On the other hand, MMP-2 tran-
cripts were detected in the normal and mdx muscles at 3.1
b, hence reflecting the constitutive expression of MMP-2. In
ormal muscles after CTX injury, the level of MMP-2 tran-
cript increased progressively. The threefold increase observed
t day 7 corresponded to the higher levels detected during
egeneration–regeneration. A slow decrease was observed
hereafter (Fig. 6B).
FIG. 3. Characterization of metalloproteinases secreted by skel-
etal muscle. (A) APMA treatment was performed on normal
extracts. Lane 1, control; Lane 2, APMA (1 mM), 1 h, 37°C. (B)
Inhibition was performed on mdx muscle extracts. After electro-
phoresis, the gels were incubated in a 100 mM Tris–HCl incubation
buffer containing either EDTA (20 mM) or PMSF (1 mM) overnight.
Both gelatinases were inhibited by EDTA, but not by PMSF.
s of reproduction in any form reserved.
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164 Kherif et al.Localization of Gelatinases Expression in Skeletal
Muscle by in Situ Hybridization
In situ hybridization performed on CTX-injured muscles
early after injury with antisense MMP-9 probe revealed the
FIG. 4. Gelatinase assay on 3H-labeled gelatin of normal and C
muscles were incubated with specific protease inhibitors AEBSF, E
Results are the means of triplicate determinations and expressed a
EM (**P # 0.05).
FIG. 5. Western blot analysis. Protein extracts of CTX-injured and
mdx muscles were analyzed by immunoblotting with anti-human
MMP-9. Equal amounts of protein (100 mg) were loaded per lane and
mmunoblotted under nonreducing conditions with rabbit poly-
lonal antiserum against 92-kDa human gelatinase diluted at
:500. Hu-A, human MMP-9 antigen (100 ng). C, 3-month-old
ormal muscle. 1, 3, 7, 10, and 30 correspond to CTX-injured
uscles at 1, 3, 7, 10, and 30 days after injury. mdx, 3-month-old
dx muscle. Molecular weights are on the left.
Copyright © 1999 by Academic Press. All rightresence of a large number of positive cells in the injured
issue. Silver grain accumulation was detected in aggregates
f inflammatory cells (Figs. 7A and 7B) identified as poly-
orphonuclear leukocytes and macrophages (data not
hown) and in mononucleated cells localized at the periph-
ry of injured myofibers (Fig. 7C). Adjacent control sections
ybridized with sense MMP-9 and pGEM control probes
ere negative (Fig. 7D9); sense MMP-9 gave high back-
round (not shown). No expression of MMP-9 was observed
n normal muscles (not shown).
In situ hybridization performed with MMP-2-riboprobe
n muscle sections did not allow the localization or the
dentification of the cellular source of MMP-2 mRNA. This
ould be due to a low number of transcripts per cell.
DISCUSSION
The aim of our work was to investigate the involvement
of MMP-2 and MMP-9 gelatinases in tissue remodeling
which occurs during skeletal muscle degeneration–
regeneration. Two situations were chosen to carry out the
injured muscles. Extracts from normal (CTRL) and CTX-injured
, and E64 to determine the relative contribution of MMP activity.
of gelatin hydrolyzed per muscle per 48 h. Bars represent means 6TX-
DTAresearch: (i) the experimentally induced regeneration by
cardiotoxin injection which induces injury in normal
s of reproduction in any form reserved.
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165MMP-2 and MMP-9 in Regenerating Musclemuscles; (ii) the spontaneous muscle regeneration which
takes place in mutant mdx mice, the murine model of
Duchenne muscular dystrophy. The capacity of myogenic
cells to produce these gelatinases was also investigated in
conditioned medium C2C12 cell line.
Our results clearly show that skeletal muscle can pro-
duce both MMP-2 and MMP-9 gelatinases as latent and/or
active forms, but with differential patterns related to the
time course of muscle necrosis and regeneration. Several
FIG. 6. Northern blot analysis and evaluation of transcriptional
activity of normal, mdx, and CTX-injured muscles. (A) 10 mg of
total RNA extracted from normal, CTX-injured, and mdx muscles
was resolved in 1.1% agarose gel under denaturing conditions and
transferred onto a nylon membrane Hybond N1. the membrane
as sequentially hybridized with mouse MMP-2 and MMP-9
DNA probes labeled with [32P]dCTP by random priming and later
with 18S oligoprobe 32P-labeled by nick translation as standard. C,
-month-old normal muscle. 1, 3, 7, 10, 14, and 30 correspond to
TX-injured muscles at 1, 3, 7, 10, 14, and 30 days after injury.
dx, 3-month-old mdx muscle. Molecular sizes are on the left. (B)
adioactivity of MMP-2- and MMP-9-labeled bands was quantified
sing a b-Imager system, normalized as the ratio between samples
ersus 18S standard activity and expressed in arbitrary units.findings indicate that these enzymes are members of the
matrix metalloproteinase family: (i) they were produced as
p
d
Copyright © 1999 by Academic Press. All rightconstitutive 60-kDa MMP-2 and inducible 100-kDa MMP-9
proenzymes that could be activated by APMA; (ii) their
activity was inhibited by metallochelators such as EDTA,
but not by phenylmethylsulfonyl fluoride; (iii) MMP-9
protein was recognized by a specific antibody; (iv) their free
gelatinolytic activity was characterized against a specific
gelatin substrate in the presence of serine and cysteine
inhibitors; and (v) mRNAs were identified by use of specific
mouse molecular probes. Conditioned medium of C2C12
myogenic cells exhibits the presence of MMP-2 latent and
active forms. In situ hybridization revealed that MMP-9
mRNA are produced by inflammatory cells predominantly
polymorphonuclear leukocytes and by putative activated
satellite cells.
Constitutive Expression of MMP-2 and Not MMP-9
by Normal Skeletal Muscle
Our zymography results demonstrate that, under basal
conditions, skeletal muscles of adult mice constitutively
express MMP-2 as 66-, 60-, and 55-kDa forms. Such differ-
ences of MMP-2 molecular masses between mouse and
human proteins have already been reported (Talhouk et al.,
1992). In mouse, the major 60-kDa form could represent a
latent unglycosylated or an intermediary form of MMP-2.
Nonetheless, the steady-state level of MMP-2 mRNA was
detectable by Northern blotting. In contrast, MMP-9 was
not detected either at the protein or at the mRNA levels.
The scarcely detectable level of free gelatinolytic activity
evaluated against 3H-labeled gelatin is in accordance with
he low level of MMP-2 active form evaluated by zymogra-
hy. This strongly suggests that the gelatinase/
ntigelatinase balance in vivo is maintained in a healthy
hysiological condition.
In situ hybridization did not allow the identification of
he cellular source of MMP-2 possibly because of low RNA
opy per cell. In normal skeletal muscle, endothelial and
broblast cells are able to produce MMP-2. Nevertheless,
y analysis of C2C12-conditioned medium we show that
yogenic cells constitutively produce MMP-2, confirming
he results of previously reported data showing that human
atellite cells express MMP-2 (Gue´rin and Holland, 1995).
Modulation of MMP-2 and MMP-9 Expression in
Cardiotoxin-Injured Skeletal Muscle
The injection of cardiotoxin, a depolarizing fragment
from snake venom Naja nigricollis, into the muscle
Duchen et al., 1974) rapidly induced muscle damage and
he inflammatory pattern was evidenced within a few hours
y our morphological study. The damaged muscles produce
oluble chemoattractants thus promoting a rapid migration
f PMNs from the vasculature to the injury site (Grounds
nd Davies, 1996). PMNs are the first infiltrating cells to
nvade the necrotic muscles and are followed by macro-
hages which become the dominant infiltrating cells by 3
ays after injury (Lefaucheur and Sebille, 1995a). In turn,
s of reproduction in any form reserved.
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166 Kherif et al.activated exsudate macrophages attract muscle precursor
cells to the site of tissue repair by producing various
enzymes, ECM products, and growth factors (Grounds and
Davies, 1996).
Our zymography, Western blot, and Northern blot data
indicate that mouse MMP-9 is extensively up-regulated
during the first 3 days following cardiotoxin injury, i.e.,
during the acute inflammatory stage that also correlates
with active proliferation of myogenic cells. Two MMP-9
mRNA types of 3 and 3.8 kb were identified in muscle
extracts due to the presence of two poly(A) sites (Reponen et
al., 1994; Tanaka et al., 1993). Between 3 and 7 days
following cardiotoxin injury the amount of MMP-9 mRNA
and protein begins to decay; both disappear by the begin-
ning of the second week. Inflammatory response in
cardiotoxin-injured muscle is acute and numerous acti-
vated PMNs and macrophages are present. In situ hybrid-
ization revealed that by day 1 after injury, these cells
express MMP-9 mRNA that was also localized to mono-
FIG. 7. In situ hybridization of day 1 CTX-injured EDL–TA muscl
ith a light H&E show several positive cells at the site of injury. (
nfiltrated inflammatory cells (identified as PMN and macrophage
atter cell types. (C) Dense silver grains are found over mononucl
atelitte cells express MMP-9 transcripts. (D) Adjacent control sec
show a differential labeling of inflammatory cells. The periphery of
3670.nucleated cells at the periphery of injured muscle fibers.
These cells may be putative activated satellite cells since
w
i
Copyright © 1999 by Academic Press. All rightmmunofluorescence with MyoD antibody exhibited a
imilar staining pattern (data not shown). Our observations
elated to MMP-9 expression by muscle precursor cells
uring early normal muscle development (unpublished re-
ults) or by cultured human satellite cells after TPA treat-
ent (Gue´rin and Holland, 1995) indicate that it is conceiv-
ble that MMP-9 expression may be induced in myoblasts.
atellite cells are activated early after injury (Grounds et al.,
992) and present cytoplasmic processes that pass through
nterruptions of parent basal lamina (Maltin et al., 1983).
hese observations and others (Bischoff, 1979; Hughes and
lau, 1990) suggest that myogenic cells have migratory
apacities. Similar regulation of MMP-9 was also observed
uring dedifferentiation/regeneration of axolotl appendages
Yang and Bryant, 1994).
Our zymography data clearly show that mouse MMP-2 is
p-regulated and activated between 3 and 10 days postin-
ury, with maximal activation at day 7. This is evidenced by
he gradual increase in free metallogelatinolytic activity
h MMP-9 RNA probe. Transverse cryostat sections counterstained
dense accumulation of silver grains was observed in aggregates of
d in B necrotic fibers are seen to be completely infiltrated by the
cells at the periphery of injured fibers, suggesting that activated
hybridized with MMP-9 antisense and (D9) pGEM control probes
tic fibers is delineated by lightly dotted black lines. Magnification,e wit
A) A
s), an
eated
tionsith a maximal response at day 7 postinjury. This time
nterval corresponds, in our study, to myogenic cell prolif-
s of reproduction in any form reserved.
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167MMP-2 and MMP-9 in Regenerating Muscleeration, migration, and fusion. By day 10, when myoblast
fusion has been completed, the latent and active forms of
MMP-2, the free metallogelatinolytic activity, and mRNA
return to baseline levels. The role played by MMP-2 during
myoblast fusion could be to degrade the type IV collagen as
well as other basement membrane macromolecular compo-
nents such as entactine (Sires et al., 1993). Our overall
results strongly suggest that MMP-2 up-regulation at
mRNA, protein, and activity levels correlates with the
regeneration.
Expression of MMP-2 and MMP-9 by Skeletal
Muscle of mdx Mice
Skeletal muscles from mdx mice exhibit recurrent signs
of degeneration and necrosis followed by successful regen-
eration (Louboutin et al., 1993; Torres and Duchen, 1987).
Foci of degenerating and regenerating myofibers exist con-
comitantly within the same muscle.
When compared to normal muscles, our zymography
results demonstrate that mdx muscles exhibited: (i) a weak
but constant expression of MMP-9 as a double band at
approximately 100 kDa and (ii) up-regulation of MMP-2 as
a major 60-kDa form and a significant level of the 55-kDa
active form. MMP-9 was identified by Western blot analy-
sis. The constitutive production of mouse MMP-2 was
corroborated by Northern blot analysis. On the basis of our
results obtained in cardiotoxin-injured muscles, it is pos-
sible to hypothesize that a constant MMP-2 activation may
intervene during muscle regeneration. Moreover, the pres-
ence of a significant level of 55-kDa active form suggests
that an imbalance between MMP-2 and its specific inhibi-
tor, TIMP-2, may develop in the microenvironment of
necrotic fibers as a result of inflammation-related factors. In
mdx muscles, the absence of dystrophin directly or indi-
rectly results in the inability of mdx fibers to maintain a
low intracellular concentration of calcium (McArdle et al.,
1995; Turner et al., 1988). This inability of cells to regulate
the calcium flux may favor activation of proteases as has
been described in dystrophic muscles (Kar and Pearson,
1978). Since MMPs require proteolytic cleavage for their
activation and since calcium ions are required to promote
catalytic site liberation, calcium increase in mdx muscles
may be one of the physiological pathways explaining the
constant MMP-2 activation. Several mdx muscles (gastroc-
nemius, soleus, diaphragm, and heart) have shown similar
expression and activation patterns (unpublished data). Nev-
ertheless, in addition to the possible involvement of in-
creased calcium flux in MMP-2 activation, other MMP-2
activation mechanisms may intervene, implying matrilysin
(Crabbe et al., 1994) or MT-MMP1, a membrane-type ma-
trix metalloproteinase (Sato et al., 1994; Yamamoto et al.,
1996).
Mouse MMP-9 is known to migrate at 105 kDa (Tanaka
et al., 1993) and the two closely related forms of MMP-9
identified by zymography might be different glycosylated
proforms. The blurred MMP-9 band identified by Western
Copyright © 1999 by Academic Press. All rightblot supports this hypothesis. However, no MMP-9 mRNA
was detectable by Northern blot analysis, either when the
total RNA loaded on gels was increased threefold or when
total RNA was isolated from highly necrotized muscles of
1-month-old mdx mice. In fact, skeletal muscles of
1-month-old mdx mice suffer chronic necrosis–
regeneration spatially limited to small foci. From this it
could be inferred that few inflammatory cells are present at
a given time. This may explain the difficulties in detecting
MMP-9 transcripts within the Northern blot detection
limits, presuming that it is produced by both inflammatory
and activated satellite cells. Numerous histological studies
have identified the presence of PMNs, macrophages (Lefau-
cheur and Sebille, 1995a), and mast cells (Gorospe et al.,
1994) in injured muscles. These cell types are known to
store (Delclaux et al., 1996) and produce MMP-9 in response
to different stimuli from necrotic tissue, and represent one
important source of MMP-9.
It is not known what factors up-regulate MMP-9 or
MMP-2 expression during the degeneration–regeneration
process. Several studies showed that MMP expression is
greatly modulated by cytokines and growth factors and
involves the gene products of Fos and Jun families of
oncogenes (Mauviel, 1993). Although they have a similar
substrate specificity, expression of the MMP-2 and MMP-9
appears to be differentially regulated (Yokoo and Kitamura,
1996) by various cytokines and chemokines produced by
degenerating muscles and activated macrophages (Robert-
son et al., 1993). MMP-9 promoter gene is characterized by
the presence of NF-kB and SP-1 binding sites in synergistic
ooperation with TRE sequence (TPA responsive element)
hich are absent in the MMP-2 gene. For example, TNF-a
and IL-1b secreted by activated macrophages up-regulate
MP-9 (Brenner et al., 1989) but do not affect MMP-2
xpression (Unemori et al., 1994; Yao et al., 1996). These
ata may explain the preferential MMP-9 up-regulation
uring acute inflammation of cardiotoxin-injured muscles.
ecause MMP-2 and MMP-9 are activated during the regen-
ration process, it is highly probable that these enzymes
lay an important role in myogenesis, partly in response to
hemokines. After injury to skeletal muscles, satellite cells
re activated, they proliferate, migrate and differentiate to
egenerate new muscle fibers. Numerous studies suggest
hat signals produced locally by the damaged muscle itself
re responsible for these events (Bischoff, 1997; Grounds
nd Davies, 1996). Several growth factors such as FGFs
Johnson and Allen, 1993), IGF, and TGF-b1 and -2 (Lefau-
cheur and Sebille, 1995b) have the ability to modulate the
proliferative activity of cultured satellite cells (Grounds and
Davies, 1996). Recently, it has been demonstrated that
HGF/SF has the ability to activate quiescent satellite cells
in vivo (Tatsumi et al., 1998) to stimulate satellite cell
migration (Bischoff, 1997) and exerts mitogenic activity on
cultured satellite cells (Allen et al., 1995). In this respect,
one of the more mechanistically relevant aspects of MMPs
implication in the regenerative process is the possibility
that either one or both type IV gelatinases could be involved
s of reproduction in any form reserved.
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168 Kherif et al.in releasing and/or cleaving matrix-associated growth fac-
tors, so that they become free to stimulate satellite cell
proliferation during the regeneration process (Anderson et
al., 1991; Clegg et al., 1987). In addition, early after muscle
injury, the gelatinase activity could be necessary to degrade
the type IV collagen thus promoting the detachment of
satellite cells from the basement membrane, and their
proliferation, migration, and subsequent differentiation. It
is noteworthy that proteases such as metalloendoprotease
(Couch and Strittmatter, 1983) and calpain (Kumar et al.,
1992) are involved in myoblast fusion which is blocked by
the addition of specific inhibitors in vitro. In this context, it
would be interesting to analyze the consequences of the
inhibition of either or both metalloproteinases in vivo to
demonstrate more precisely the involvement of MMP-2 and
MMP-9 in skeletal muscle degeneration and regeneration.
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